首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections.
【24h】

CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections.

机译:患有严重原发性呼吸道合胞病毒感染的婴儿的支气管肺泡灌洗液和外周血单核细胞中的CD8 + T细胞反应。

获取原文
获取原文并翻译 | 示例
           

摘要

A protective role for CD8+ T cells during viral infections is generally accepted, but little is known about how CD8+ T cell responses develop during primary infections in infants, their efficacy, and how memory is established after viral clearance. We studied CD8+ T cell responses in bronchoalveolar lavage (BAL) samples and blood of infants with a severe primary respiratory syncytial virus (RSV) infection. RSV-specific CD8+ T cells with an activated effector cell phenotype: CD27+CD28+CD45RO+CCR7-CD38+HLA-DR+Granzyme B+CD127- could be identified in BAL and blood. A high proportion of these CD8+ T cells proliferated and functionally responded upon in vitro stimulation with RSV Ag. Thus, despite the very young age of the patients, a robust systemic virus-specific CD8+ T cell response was elicited against a localized respiratory infection. RSV-specific T cell numbers as well as the total number of activated effector type CD8+ T cells peaked in blood around day 9-12 after the onset of primary symptoms, i.e., at the time of recovery. The lack of a correlation between RSV-specific T cell numbers and parameters of disease severity make a prominent role in immune pathology unlikely, in contrast the T cells might be involved in the recovery process.
机译:人们普遍接受CD8 + T细胞在病毒感染期间的保护作用,但对于婴儿初次感染CD8 + T细胞的反应方式,其功效以及清除病毒后如何建立记忆的了解很少。我们研究了患有严重原发性呼吸道合胞病毒(RSV)感染的婴儿的支气管肺泡灌洗(BAL)样本和血液中的CD8 + T细胞应答。可在BAL和血液中鉴定出具有激活的效应细胞表型的RSV特异性CD8 + T细胞:CD27 + CD28 + CD45RO + CCR7-CD38 + HLA-DR +粒酶B + CD127-。这些CD8 + T细胞中有很大一部分在体外受RSV Ag刺激后增殖并发生功能性反应。因此,尽管患者年龄很小,但仍引起了针对全身性呼吸道感染的强烈的全身性病毒特异性CD8 + T细胞应答。 RSV特异性T细胞数量以及活化的效应型CD8 + T细胞总数在主要症状发作后即恢复时的第9-12天左右在血液中达到峰值。 RSV特异性T细胞数量与疾病严重程度参数之间缺乏相关性,使得不可能在免疫病理学中扮演重要角色,相反,T细胞可能参与恢复过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号